This highly sensitive chemiluminescent microparticle immuno assay (CMIA) assists in the early and enhanced detection of HBV in human serum and plasma (blood) samples and in population screening, Abbott said in a statement.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/sGVjXBg
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Abbott launches solution to detect Hepatitis B virus
https://ift.tt/Kl6WLZb
No comments:
Post a Comment